1,572
Participants
Start Date
August 1, 2024
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2030
Metformin
Individuals randomized to this arm will receive oral metformin tablets for their Gestational diabetes mellitus treatment.
Insulin
Individuals randomized to this arm will receive injectable insulin for their Gestational diabetes mellitus treatment.
RECRUITING
Columbia University Irving Medical Center, New York
RECRUITING
University of Pittsburgh, Pittsburgh
RECRUITING
Christiana Care, Newark
RECRUITING
Eastern Virginia Medical School - Old Dominion University, Norfolk
RECRUITING
Wake Forest University, Winston-Salem
RECRUITING
University of South Carolina Greenville, Greenville
RECRUITING
University of South Florida, Tampa
RECRUITING
University of Alabama, Tuscaloosa
RECRUITING
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus
RECRUITING
Premier Health - Miami Valley Hospital, Dayton
RECRUITING
University of Texas Health Science Center, Houston
RECRUITING
University of Texas Austin, Austin
RECRUITING
University of New Mexico, Albuquerque
RECRUITING
Cedars Sinai Medical Center, Los Angeles
RECRUITING
University of California San Francisco, San Francisco
RECRUITING
Tufts University, Boston
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Beth Israel Deaconess Medical Center, Boston
RECRUITING
Brown University, Providence
Patient-Centered Outcomes Research Institute
OTHER
The George Washington University Biostatistics Center
OTHER
Ohio State University
OTHER